MedTrace Logo

In Vivo Preoperative Skin Preparation Efficacy Study Within a Defined Product Coverage Area

NCT03681990 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 28

Last updated 2024-10-02

Study results available
· View outcomes & findings →

Summary

This study evaluates reduction of resident flora produced by the test product within a defined prepped area of skin.

Conditions

  • Surgical Skin Preparation
  • Surgical Procedure, Unspecified

Interventions

DRUG

3M CHG/IPA Prep

Apply topically to intact skin

Sponsors & Collaborators

  • 3M

    collaborator INDUSTRY

  • Solventum US LLC

    lead INDUSTRY

Principal Investigators

  • Rozalia Olsavszky, MD · Eurofins/Evic

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-06-06
Primary Completion
2017-07-04
Completion
2017-07-04
FDA Drug
Yes

Countries

  • Romania

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03681990 on ClinicalTrials.gov